NCT06239649 The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty
| NCT ID | NCT06239649 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pamukkale University |
| Condition | Knee Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-10-19 |
| Primary Completion | 2024-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2023-10-19 with a primary completion date of 2024-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In our study, investigators plan to compare the preoperative RF and genicular nerve ablation approach in patients who underwent TKA(Total Knee Arthroplasty) using the Fast-Track protocol in terms of meeting postoperative pain, function and early discharge criteria.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 40 and 85, * Being able to understand verbal and written information given in Turkish, * Being able to speak and understand Turkish, * Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis Exclusion Criteria: * Patients planned for revision knee prosthesis surgery, * Patients previously diagnosed with psychiatric disorders, * Patients who have undergone major surgery on the extremity where TKA will be applied, * Patients with comorbid diseases such as rheumatoid arthritis or cancer, * Patients with a score above 3 according to the American Society of Anesthesiologists (ASA) scoring, * Patients with neurological diseases that cause functional disability, * Patients with flexion limitation of more than 45 degrees and extension limitation of more than 20 degrees, * Patients who have to use hypnotic or anxiolytic drugs regularly, * Patients with alcohol or drug addiction, * Patients with bleeding disorders * Patients with uncontrolled diabetes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06239649 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239649 currently recruiting?
Yes, NCT06239649 is actively recruiting participants. Contact the research team at hrgungor@gmail.com for enrollment information.
Where is the NCT06239649 trial being conducted?
This trial is being conducted at Denizli, Turkey (Türkiye).
Who is sponsoring the NCT06239649 clinical trial?
NCT06239649 is sponsored by Pamukkale University. The trial plans to enroll 60 participants.